Stem Cell Research (Aug 2021)

Establishment of an integration-free human induced pluripotent stem cell line (TJCi001-A) from normal bone marrow-derived mesenchymal stem cells

  • Na Young Choi,
  • YuRa Lee,
  • Yo Seph Park,
  • Kinarm Ko,
  • BoonSaeng Park,
  • Yong-Gon Koh

Journal volume & issue
Vol. 55
p. 102484

Abstract

Read online

Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess excellent therapeutic potential for the treatment of various diseases including graft-versus-host disease, rheumatoid arthritis, osteoarthritis, and multiple sclerosis. Here, we generated an induced pluripotent stem cell (iPSC) line from BM-MSCs employing a non-integrating episomal vector. The generated iPSCs expressed pluripotency markers, showed a normal karyotype, and exhibited the potential for in vitro differentiation into three germ layers. This iPSC line can be used as a healthy control in stem cell therapeutics and disease modeling studies.